Skip to main content

Advertisement

Open Peer Review Reports for: Axitinib, cabozantinib, or everolimus in the treatment of prior sunitinib-treated patients with metastatic renal cell carcinoma: results of matching-adjusted indirect comparison analyses

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
25 May 2018 Submitted Original manuscript
15 Aug 2018 Reviewed Reviewer Report - Reza Elaidi
22 Aug 2018 Reviewed Reviewer Report - Ian Davis
21 Sep 2018 Author responded Author comments - Irina Proskorovsky
Resubmission - Version 2
21 Sep 2018 Submitted Manuscript version 2
24 Sep 2018 Reviewed Reviewer Report - Ian Davis
2 Nov 2018 Reviewed Reviewer Report - Reza Elaidi
27 Nov 2018 Author responded Author comments - Irina Proskorovsky
Resubmission - Version 3
27 Nov 2018 Submitted Manuscript version 3
Publishing
29 Nov 2018 Editorially accepted
19 Dec 2018 Article published 10.1186/s12885-018-5157-0

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement